Polymer colloids as drug delivery systems for the treatment of arthritis

Arthritis Research UK Park, 2018, Various types of Arthritis in the United States: prevalence and age-related trends from 1999 to 2014, Am J Public Health, 108, 256, 10.2105/AJPH.2017.304179 World Health Organization, 2018 Bansal, 2007, New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly, Drugs Aging, 24, 441, 10.2165/00002512-200724060-00001 Ashkavand, 2013, The pathophysiology of osteoarthritis, J Pharm Res, 7, 132 Mobasheri, 2016, An update on the pathophysiology of osteoarthritis, Ann Phys Rehabil Med, 59, 333, 10.1016/j.rehab.2016.07.004 Palazzo, 2016, Risk factors and burden of osteoarthritis, Ann Phys Rehabil Med, 59, 134, 10.1016/j.rehab.2016.01.006 Thakur, 2018, Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: an overview, Biomed Pharmacother, 106, 1011, 10.1016/j.biopha.2018.07.027 Sharma, 2007 Kidd, 2012, Mechanisms of pain in osteoarthritis, HSS J, 8, 26, 10.1007/s11420-011-9263-7 Gerwin, 2006, Intraarticular drug delivery in osteoarthritis, Adv Drug Deliv Rev, 58, 226, 10.1016/j.addr.2006.01.018 Haq, 2003, Osteoarthritis, Postgrad Med J, 79, 377, 10.1136/pmj.79.933.377 Berenbaum, 2013, Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!), Osteoarthr Cartil, 21, 16, 10.1016/j.joca.2012.11.012 Grässel, 2017, 27 Emery, 2002, Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide, Ann Rheum Dis, 61, 290, 10.1136/ard.61.4.290 Aletaha, 2010, Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 National Clinical Guideline Centre (UK), 2014 Muller, 2018, Rheumatoid arthritis, Integr Med, 27, 501 Bullock, 2019, Rheumatoid arthritis: a brief overview of the treatment, Med Princ Pract, 27, 501, 10.1159/000493390 Hajialilo, 2016, A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis, Clin Rheumatol, 35, 2887, 10.1007/s10067-016-3397-4 Perkins, 2017, Steroids and osteoarthritis, J Arthritis, 06, 10.4172/2167-7921.1000e115 Perni, 2017, Poly-beta-amino-esters nano-vehicles based drug delivery system for cartilage, Nanomed Nanotechnol Biol Med, 13, 539, 10.1016/j.nano.2016.10.001 Wernecke, 2015, The effect of intra-articular corticosteroids on articular cartilage: a systematic review, Orthop J Sports Med, 3, 10.1177/2325967115581163 He, 2017, An overview of hydrogel-based intra-articular drug delivery for the treatment of osteoarthritis, Colloids Surf B Biointerfaces, 154, 33, 10.1016/j.colsurfb.2017.03.003 Huang, 2012, Micro- and nano-carrier mediated intra-articular drug delivery systems for the treatment of osteoarthritis, J Nanotechnol, 1687 Hochberg, 2000, Osteoarthritis: new insights. Part 2: treatment approaches, Ann Intern Med, 133, 726, 10.7326/0003-4819-133-9-200011070-00015 Zachwieja, 2017, Hip and knee arthroplasty in osteoarthritis, Curr Treat Options Rheum, 3, 75, 10.1007/s40674-017-0063-1 Pajarinen, 2014, Interaction of materials and biology in total joint replacement - successes, challenges and future directions, J Mater Chem B, 2, 7094, 10.1039/C4TB01005A Maradit Kremers, 2015, Prevalence of Total hip and knee replacement in the United States, J Bone Joint Surg Am, 97, 1386, 10.2106/JBJS.N.01141 McLawhorn, 2017, Bundled payments in total joint replacement: keeping our care affordable and high in quality, Curr Rev Musculoskelet Med, 10, 370, 10.1007/s12178-017-9423-6 Chen, 2012, TGF-β and BMP signaling in osteoblast differentiation and bone formation, Int J Biol Sci, 8, 272, 10.7150/ijbs.2929 Witteveen, 2015, Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle, Cochrane Database Syst Rev, 10 Geiger, 2018, Designing drug delivery systems for articular joints, Chem Eng Prog, 5, 1 Francis, 2018, Cartilage tissue engineering using stem cells and bioprinting technology-barriers to clinical translation, Front Surg, 5, 70, 10.3389/fsurg.2018.00070 Evans, 2014, Progress in intra-articular therapy, Nat Rev Rheumatol, 10, 11, 10.1038/nrrheum.2013.159 Bajpayee, 2016, Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term, Osteoarthr Cartil, 24, 71, 10.1016/j.joca.2015.07.010 Sophia Fox, 2009, The basic science of articular cartilage: structure, composition, and function, Sports Health, 1, 461, 10.1177/1941738109350438 Carballo, 2017, Basic science of articular cartilage, Clin Sports Med, 36, 413, 10.1016/j.csm.2017.02.001 Zhang, 2009, The role of tissue engineering in articular cartilage repair and regeneration, Crit Rev Biomed Eng, 37, 1, 10.1615/CritRevBiomedEng.v37.i1-2.10 Edwards, 2011, Intra-articular drug delivery: the challenge to extend drug residence time within the joint, Vet J, 190, 15, 10.1016/j.tvjl.2010.09.019 Coleman, 1997, Hyaluronan secretion into the synovial cavity of rabbit knees and comparison with albumin turnover, J Physiol, 503, 645, 10.1111/j.1469-7793.1997.645bg.x Janssen, 2014, Drugs and polymers for delivery systems in OA joints: clinical needs and opportunities, Polymers, 6, 799, 10.3390/polym6030799 Hoffman, 2008, The origins and evolution of “controlled” drug delivery systems, J Control Release, 132, 153, 10.1016/j.jconrel.2008.08.012 Soussan, 2009, Drug delivery by soft matter: matrix and vesicular carriers, Angew Chem Int Ed Engl, 48, 274, 10.1002/anie.200802453 Yang, 2014, Progress in intra-articular drug delivery systems for osteoarthritis, Curr Drug Targets, 15, 888, 10.2174/1389450115666140804155830 Roseti, 2019, Articular cartilage regeneration in osteoarthritis, Cells, 8, 1305, 10.3390/cells8111305 Fortier, 2011, The role of growth factors in cartilage repair, Clin Orthop Relat Res, 469, 2706, 10.1007/s11999-011-1857-3 Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J Nanobiotechnol, 16, 71, 10.1186/s12951-018-0392-8 Sanna, 2014, Targeted therapy using nanotechnology: focus on cancer, Int J Nanomedicine, 9, 467 Rizvi, 2018, Applications of nanoparticle systems in drug delivery technology, Saudi Pharm J, 26, 64, 10.1016/j.jsps.2017.10.012 Kang, 2020, Acid-activatable polymeric curcumin nanoparticles as therapeutic agents for osteoarthritis, Nanomed Nanotechnol Biol Med, 23, 10.1016/j.nano.2019.102104 Crivelli, 2019, Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis, Eur J Pharm Biopharm, 137, 37, 10.1016/j.ejpb.2019.02.008 Cetin, 2010, Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium, AAPS PharmSciTech, 11, 1250, 10.1208/s12249-010-9489-6 Narayanan, 2013, Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug ibuprofen-sodium: an in vitro and in vivo analysis, Nanomedicine, 9, 818, 10.1016/j.nano.2013.02.001 Zhou, 2015, In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis, Int Immunopharmacol, 28, 34, 10.1016/j.intimp.2015.05.014 Lu, 2011, Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis, Int J Pharm, 420, 358, 10.1016/j.ijpharm.2011.08.046 Ishihara, 2010, Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents, Int J Pharm, 385, 170, 10.1016/j.ijpharm.2009.10.025 Chandrasekar, 2007, Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery, J Biomed Mater Res A, 82, 92, 10.1002/jbm.a.31122 Han, 2012, Synthesis and characterization of selenium-chondroitin sulfate nanoparticles, Carbohydr Polym, 90, 122, 10.1016/j.carbpol.2012.04.068 Lin, 2016, Controlled release of anti-inflammatory peptides from reducible thermosensitive nanoparticles suppresses cartilage inflammation, Nanomed Nanotechnol Biol Med, 12, 2095, 10.1016/j.nano.2016.05.010 Mohanty, 2019, Novel drug delivery systems for rheumatoid arthritis: an approach to better patient compliance, Biomed Pharmacol J, 12, 157, 10.13005/bpj/1624 Kapoor, 2014, Application of liposomes in treatment of rheumatoid arthritis: quo vadis, ScientificWorldJournal, 2014, 978351, 10.1155/2014/978351 Vanniasinghe, 2009, The potential of liposomal drug delivery for the treatment of inflammatory Arthritis, Semin Arthritis Rheum, 39, 182, 10.1016/j.semarthrit.2008.08.004 Bias, 2001, Sustained-release dexamethasone palmitate, Clin Drug Investig, 21, 429, 10.2165/00044011-200121060-00006 Maudens, 2018, Recent advances in intra-articular drug delivery systems for osteoarthritis therapy, Drug Discov Today, 23, 1761, 10.1016/j.drudis.2018.05.023 Hunter, 2019, Single intra-articular injection of TLC599 provided sustained pain relief through 24 weeks in participants with symptomatic knee osteoarthritis, Osteoarthr Cartil, 27, 10.1016/j.joca.2019.02.124 Maudens, 2018, Nanocrystal-polymer particles: extended delivery carriers for osteoarthritis treatment, Small, 14 Ulmansky, 2012, Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines, J Control Release, 160, 299, 10.1016/j.jconrel.2011.12.024 Dong, 2013, Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model, Int J Pharm, 441, 285, 10.1016/j.ijpharm.2012.11.031 Elron-Gross, 2009, Liposomal dexamethasone-diclofenac combinations for local osteoarthritis treatment, Int J Pharm, 376, 84, 10.1016/j.ijpharm.2009.04.025 Metselaar, 2004, Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis, Ann Rheum Dis, 63, 348, 10.1136/ard.2003.009944 Hofkens, 2011, Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide, Int J Pharm, 416, 493, 10.1016/j.ijpharm.2011.02.062 Craciunescu, 2013, Liposomal formulation of chondroitin sulfate enhances its antioxidant and anti-inflammatory potential in L929 fibroblast cell line, J Liposome Res, 23, 145, 10.3109/08982104.2013.770016 Harigai, 2007, Prednisolone phosphate-containing TRX-20 liposomes inhibit cytokine and chemokine production in human fibroblast-like synovial cells: a novel approach to rheumatoid arthritis therapy, J Pharm Pharmacol, 59, 137, 10.1211/jpp.59.1.0018 Ji, 2019, Glucosamine sulphate-loaded distearoyl phosphocholine liposomes for osteoarthritis treatment: combination of sustained drug release and improved lubrication, Biomater Sci, 7, 2716, 10.1039/C9BM00201D Lu, 2010, Emulsions and microemulsions for topical and transdermal drug delivery, 59 Jagdale, 2018, Development of microemulsion based Nabumetone transdermal delivery for treatment of Arthritis, Recent Pat Drug Deliv Formul, 12, 130, 10.2174/1872211312666180227091059 Gokhale, 2019, Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies, Biomed Pharmacother, 112 Goindi, 2016, Microemulsion-based topical hydrogels of tenoxicam for treatment of arthritis, AAPS PharmSciTech, 17, 597, 10.1208/s12249-015-0383-0 Gan, 2013, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov Today, 18, 290, 10.1016/j.drudis.2012.10.005 Rai, 2018, Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications, J Control Release, 270, 203, 10.1016/j.jconrel.2017.11.049 Changez, 2000, Aerosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride, Drug Dev Ind Pharm, 26, 507, 10.1081/DDC-100101261 Vanek, 2012, A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions, Nutr Clin Pract, 27, 150, 10.1177/0884533612439896 Szczepanowicz, 2010, Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption, Langmuir, 26, 12592, 10.1021/la102061s Bajpayee, 2017, Cartilage-targeting drug delivery: can electrostatic interactions help?, Nat Rev Rheumatol, 13, 183, 10.1038/nrrheum.2016.210 Perni, 2020, Optimisation and feature selection of poly-beta-amino-ester as a drug delivery system for cartilage, J Mater Chem B, 10.1039/C9TB02778E Bajpayee, 2014, Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis, Biomaterials, 35, 538, 10.1016/j.biomaterials.2013.09.091 Vedadghavami, 2019, Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues, Acta Biomater, 93, 258, 10.1016/j.actbio.2018.12.004 Caló, 2015, Biomedical applications of hydrogels: A review of patents and commercial products, European Polymer Journal, 65, 252, 10.1016/j.eurpolymj.2014.11.024 Santhosh, 2016, Intra-articular drug delivery systems for arthritic diseases: overcoming the inadequacies of therapy, Indo Am J Pharm Res, 6, 4427 Balazs, 1993, Viscosupplementation: a new concept in the treatment of osteoarthritis, J Rheumatol Suppl, 39, 3 Goldberg, 2010, Intra-articular hyaluronans: the treatment of knee pain in osteoarthritis, J Pain Res, 3, 51, 10.2147/JPR.S4733 Decker, 1959, Concentration of hyaluronic acid in synovial fluid, Clin Chem, 5, 465, 10.1093/clinchem/5.5.465 Reinmüller, 2003, Hyaluronic acid, Aesthet Surg J, 23, 309, 10.1016/S1090-820X(03)00158-4 Bowman, 2018, Recent advances in hyaluronic acid based therapy for osteoarthritis, Clin Transl Med, 7, 10.1186/s40169-017-0180-3 Ghosh, 2018, Methotrexate aspasomes against rheumatoid arthritis: optimized hydrogel loaded liposomal formulation with in vivo evaluation in Wistar rats, AAPS PharmSciTech, 19, 1320, 10.1208/s12249-017-0939-2 Chejara, 2017, Synthesis and evaluation of a sodium alginate-4-aminosalicylic acid based microporous hydrogel for potential viscosupplementation for joint injuries and arthritis-induced conditions, Mar Drugs, 15, 1, 10.3390/md15080257 Yin, 2020, Intra-articular injection of indomethacin-methotrexate: in situ hydrogel for the synergistic treatment of rheumatoid arthritis, J Mater Chem B, 8, 993, 10.1039/C9TB01795J Lu, 2013, Injectable hyaluronic-acid-doxycycline hydrogel therapy in experimental rabbit osteoarthritis, BMC Vet Res, 9, 1, 10.1186/1746-6148-9-68 Hui, 2007, Intra-articular delivery of chondroitin sulfate for the treatment of joint defects in rabbit model, J Mol Histol, 38, 483, 10.1007/s10735-007-9120-7 Kesharwani, 2019, Rheumatiod arthritis: an updated overview of latest therapy and drug delivery, Australas J Pharm, 22, 210 Marin, 2013, Critical evaluation of biodegradable polymers used in nanodrugs, Int J Nanomedicine, 8, 3071 Malik, 2000, Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo, J Control Release, 65, 133, 10.1016/S0168-3659(99)00246-1 Bajpayee, 2017, Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis, Eur Cell Mater, 34, 341, 10.22203/eCM.v034a21